Endothelin-1 promotes phosphorylation of CREB transcription factor in primary cultures of neonatal rat cardiac myocytes: implications for the regulation of c-jun expression  by Harrison, Joanne G et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1644 (2004) 17–25Endothelin-1 promotes phosphorylation of CREB transcription factor
in primary cultures of neonatal rat cardiac myocytes:
implications for the regulation of c-jun expression
Joanne G. Harrison, Peter H. Sugden, Angela Clerk*
NHLI Division (Cardiac Medicine Section), Faculty of Medicine, Imperial College London, Flowers Building, Armstrong Road, South Kensington,
London SW7 2AZ, UKReceived 1 July 2003; received in revised form 20 October 2003; accepted 31 October 2003Abstract
Cardiac myocyte hypertrophy is associated with an increase in expression of immediate early genes (e.g. c-jun) via activation of pre-
existing transcription factors. The activity of CREB transcription factor is regulated through phosphorylation of Ser-133 by one of several
protein kinases (e.g. protein kinase A (PKA), p90 ribosomal S6 kinases (RSKs) and the related kinase, MSK1). A cell-permeable form of
cAMP, hypertrophic agonists (endothelin-1 (ET-1), phenylephrine (PE)) and hyperosmotic shock all promoted phosphorylation of
CREB(Ser-133) in rat neonatal cardiac myocytes. The response to endothelin-1 required the extracellular signal-regulated kinase cascade
which stimulates both RSKs and MSK1. Phosphorylation of CREB(Ser-133) in response to ET-1 was not associated with any increase in
DNA binding to a consensus cAMP-response element (CRE). The rat c-jun promoter contains elements which may bind either c-Jun/ATF2 or
CREB/ATF1 dimers. Using extracts from rat cardiac myocytes, we identified at least two complexes which bind to the most proximal of these
elements, one of which contained CREB and the other c-Jun. Thus, phosphorylation and activation of CREB in cardiac myocytes may be
effected by a range of different stimuli to influence the expression of immediate early genes such as c-jun.
D 2003 Elsevier B.V. All rights reserved.Keywords: Cardiac myocyte; Immediate early gene; Intracellular signaling; CREB; Mitogen-activated protein kinase1. Introduction
Cardiac myocytes are terminally differentiated cells. In
order to adapt to chronic increases in cardiac workload,
individual cardiac myocytes undergo hypertrophic growth
[1,2]. This is associated with morphological changes (in-
creased cell size and myofibrillogenesis) and changes in
gene expression. The latter include the rapid upregulation of
immediate early genes, many of which encode transcription
factors (e.g. c-jun) and, later, the recapitulation of a ‘‘fetal’’
pattern of gene expression and upregulation of genes
encoding constitutively expressed contractile proteins
[3,4]. The primary inducers of hypertrophy are not clear,
but the response is likely to be mediated, at least in part, by0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: a.clerk@imperial.ac.uk (A. Clerk).autocrine/paracrine effects of locally released agents such as
the vasoactive peptide endothelin-1 (ET-1) or norepineph-
rine (acting through the a1-adrenoceptor). In primary cul-
tures of neonatal rat ventricular myocytes, both ET-1 and the
pharmacological a-adrenergic agonist phenylephrine (PE)
induce many of the alterations seen in hypertrophy in vivo.
A number of studies have focused on the elucidation of
the intracellular signaling pathways which are activated in
cardiac myocyte hypertrophy and which mediate the re-
sponse [5]. ET-1 and PE stimulate Gq protein-coupled
receptors to activate protein kinase C (PKC) isoforms
(PKCy and PKCq), the small G protein Ras and the
extracellular signal-regulated kinase 1/2 (ERK1/2) cascade,
all of which are particularly implicated in cardiac myocyte
hypertrophy. In addition to ERKs, other subfamilies of the
mitogen-activated protein kinases (MAPKs), the c-Jun N-
terminal kinases (JNKs) and p38-MAPKs, are activated by
ET-1 and PE, although the role(s) of these MAPKs in
hypertrophy remains to be established. MAPKs phosphor-
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trans-activating activities and, in this way, MAPKs may
influence gene expression.
The transcription factor cAMP-response element binding
protein (CREB) was identified as a 43 kDa phosphoprotein
which binds to a cAMP-response element (CRE) in the
promoters of many genes [6,7]. Although initially shown to
be activated by phosphorylation of Ser-133 by cAMP-depen-
dent protein kinase (protein kinase A, PKA), CREB(Ser-133)
phosphorylation may be mediated by a number of different
protein kinases. In addition to Ca2 +/calmodulin-dependent
kinases, both ERKs and p38-MAPKs promote CREB(Ser-
133) phosphorylation by activation of a common downstream
kinase, MSK1. ERKs also activate p90 ribosomal S6 kinases
(RSKs), which can phosphorylate CREB(Ser-133). There are
a number of ways in which phosphorylation of CREB(Ser-
133) can influence CRE-dependent gene expression [6].
Probably most significantly, phosphorylation of CREB(Ser-
133) is required for CREB trans-activating activity. In
addition, association of CREB binding protein (CBP) with
phosphorylated CREB(Ser-133) results in histone acetylation
to facilitate gene expression [8]. Furthermore, phosphoryla-
tion of CREB(Ser-133) may increase its affinity for DNA to
promote DNA-binding and CRE-dependent gene expression,
but this is not seen in all systems [6].
Cardiospecific overexpression of a non-phosphorylatable
form of CREB (which acts in a dominant-negative fashion)Fig. 1. Phosphorylation of CREB(Ser-133) in cardiac myocytes. Myocytes were u
AM PE (C), or 0.5 M sorbitol (D) for the times indicated. Nuclear extracts were W
total CREB (lower blots). Blots were analyzed by scanning densitometry (lower pa
1, PE) independent preparations of myocytes.results in dilated cardiomyopathy [9], suggesting that CREB
is essential for normal functioning of the heart. As expected,
CREB(Ser-133) phosphorylation is rapidly ( < 10 min) in-
creased in cardiac myocytes in response to adenylyl cyclase
activation by forskolin or isoproterenol presumably via
PKA [10]. An increase in phosphorylated CREB(Ser-133)
is also detected in myocytes subjected to prolonged hypoxia
in the presence of insulin-like growth factor 1, but this
requires the ERK cascade and phosphatidylinositol 3Vkinase
rather than PKA [11]. Although PE activates MSK1 in adult
rat cardiac myocytes [12], to our knowledge, there has been
no systematic investigation of the phosphorylation and
activation of CREB in myocytes. Here, we have investigat-
ed the effects of hypertrophic stimuli on the phosphorylation
and DNA-binding activity of CREB in neonatal rat ventric-
ular cardiac myocytes.2. Materials and methods
2.1. Cell culture
Myocytes were isolated from the ventricles of neonatal
Sprague–Dawley rats as previously described [13]. Cells
were plated at a density of 1.4 103 cells/mm2 in 4:1 (v/v)
DMEM/M199 containing 10% (v/v) horse serum, 5% (v/v)
fetal calf serum and 100 U/ml each of penicillin and strepto-nstimulated or exposed to 100 AM CPT-cAMP (A), 100 nM ET-1 (B), 100
estern blotted with antibodies to phospho-CREB(Ser-133) (upper blots) or
nels). Results are meansF S.E. for three (sorbitol) or four (CTP-cAMP, ET-
Fig. 2. ET-1 stimulation of phospho-CREB(Ser-133) requires the ERK and
p38-MAPK cascades. Myocytes were unstimulated (Control), exposed to
10 AM U0126 or 10 AM SB203580, or exposed to ET-1 (100 nM, 5 min) in
the absence or presence of inhibitors. Nuclear extracts were Western blotted
with antibodies to phospho-CREB(Ser-133) (upper blot) or total CREB
(lower blot). Blots were analyzed by scanning densitometry (lower panel).
Results are meansF S.E. for three independent preparations of myocytes.
*P < 0.0001; #P < 0.01 relative to ET-1 alone (unpaired Student’s t-test).
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Rat embryonic fibroblasts were provided by Professor John
Couchman (Division of Biomedical Sciences, Imperial Col-
lege London) and were cultured in MEM alpha medium
containing 10% (v/v) fetal calf serum and 100 U/ml each of
penicillin and streptomycin. Fibroblasts were cultured to 80–
90% confluence and serum was withdrawn 24 h prior to
experimentation. For inhibitor experiments, cells were ex-
posed to inhibitor (15 min) prior to the addition of ET-1.
2.2. Preparation of nuclear extracts
Nuclear extracts were prepared as previously described
[14]. Briefly, cells were harvested into Buffer A (10 mM
Tris–HCl pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.3 mM
Na3VO4, 0.2 mM leupeptin, 0.01 mM trans-epoxysuccinyl-
L-leucylamido-(4-guanidino) butane (E64), 5 mM dithio-
threitol (DTT), 0.3 mM phenylmethylsulfonyl flouride
(PMSF), 2 AM microcystin LR). Samples were centrifuged
(4 jC, 5 min, 10,000 g) and the supernatants discarded.
Pellets were washed in Buffer A containing 0.1% (v/v)
Nonidet P40 and nuclear proteins were extracted in Buffer B
(20 mM HEPES pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 25% (v/v) glycerol, 0.3 mM Na3VO4, 0.2 mM
leupeptin, 0.01 mM E64, 5 mM DTT, 0.3 mM PMSF, 2 AM
microcystin LR). Protein concentrations were determined by
the Bradford method [15]. For electrophoretic mobility shift
assays (EMSAs), aliquots of nuclear extracts were snap
frozen in liquid nitrogen and stored at  80 jC. For Western
blot analysis, nuclear extracts were boiled with 0.33 vol.
SDS sample buffer (0.33 M Tris–HCl, pH 6.8, 10% (w/v)
SDS, 13% (w/v) glycerol, 2% DTT, 0.01% (w/v) bromo-
phenol blue).
2.3. Electrophoretic mobility shift assays
Oligonucleotides containing consensus AP-1 (cAP-1, 5V-
CGCTTGATGACTCAGCCGGAA-3V) and consensus CRE
(cCRE, 5V-AGAGATTGCCTGACGTCAGAGAGCTAG-3V)
sequences were from Santa Cruz Biotechnology. Oligonu-
cleotides were also generated to the proximal CRE/AP-1-
like (jun1) sequence ( 78 to  57) of the rat c-jun
promoter (5V-CTTGGGGTGACATCATGGGCT-3V) and the
heat shock element (HSE) of heat shock protein 70
(Hsp70, 5 V-TAACAGACCCGAAACTGCTGGAA-
GATTCCT-3V) by Sigma Genosys. Oligonucleotides were
5Vend-labeled with [g-32P] ATP by incubating (37 jC, 30
min) with forward reaction buffer (70 mM Tris–HCl, pH
7.6, 10 mM MgCl2, 5 mM DTT), 10 U of T4 polynucle-
otide kinase (Promega) and 15 ACi [g-32P]ATP. Unincor-
porated [g-32P]ATP was removed using a chromospin
column (pore size 10) in TE buffer (10 mM Tris–HCl,
pH 8.0, 1 mM EDTA). Nuclear extracts (10 Ag) were
incubated (10 min, 20 jC) in binding buffer (50 mM Tris–
HCl pH 7.5, 250 mM NaCl, 5 mM EDTA, 25% (v/v)
glycerol, 1 mM DTT, 1 Ag poly dI–dC) in a 20 Al finalvolume. Unlabeled cAP-1, cCRE, jun1 and Hsp70 oligo-
nucleotides (0.4–40 ng) were also added for competition
experiments. For the binding reaction, radiolabeled oligo-
nucleotide (0.4 ng) was added to the nuclear extracts and
incubated (20 min, 20 jC). For super-shift assays, 1 or 2
Ag CREB, c-Jun or JunB primary antibodies (Santa Cruz,
supplied by Autogen Bioclear) were incubated with 3 Ag
nuclear extract (1 h, 4 jC) prior to the addition of the
binding buffer and radiolabeled oligonucleotide. DNA–
protein complexes were separated on a 4% (w/v) non-
denaturing polyacrylamide gel containing 50 mM Tris–
HCl pH 8.3, 0.38 M glycine, 2 mM EDTA, 0.2 mM DTT
(120 V, 3 h). The gels were dried and exposed to Hyper-
film MP (Amersham Pharmacia Biotech) for 2–48 h.
Semi-quantitative analysis of the bands was performed
by scanning densitometry (Image master 1D prime version
3.0, Amersham Pharmacia Biotech).
2.4. Western blot analysis
Proteins in nuclear extracts (25 Ag) were separated by
SDS/polyacrylamide gel electrophoresis on 10% polyacryl-
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branes using Towbin transfer buffer (25 mM Tris, 192 mM
glycine, 20% (v/v) methanol). Non-specific binding was
blocked by incubating blots (20 min, room temperature) in
5% (w/v) non-fat milk powder in Tris-buffered saline
containing 0.1% (v/v) Tween 20 (TBST). Primary anti-
bodies specific to CREB and phosphorylated CREB(Ser-
133) (Cell Signaling) were diluted in TBST containing 5%
(w/v) BSA and incubated with the blots (1:1000 dilution, 16
h, 4 jC). The membranes were washed in TBST (3 5 min,
room temperature), and incubated with horseradish peroxi-
dase-linked secondary antibodies (1:5000 dilution in TBST
containing 1% (w/v) milk powder, 1 h, 20 jC). Blots were
washed in TBST (3 5 min) and bands were visualised by
enhanced chemiluminescence using luminol reagent (Santa
Cruz Biotechnology) with exposure to Hyperfilm MP for
1–5 min. Semi-quantitative analysis of the bands was
performed by scanning densitometry.3. Results
3.1. Phosphorylation of CREB in cardiac myocytes
Phosphorylation of Ser-133 of CREB is necessary for
CREB trans-activating activity [6]. Although CREB wasFig. 3. Transcription factor binding to a cCRE sequence does not change in res
neonatal ventricular myocytes (B) were unstimulated or exposed to 100 nM ET-1
radiolabeled oligonucleotide containing a cCRE sequence. The free probe can b
analysis of autoradiographs represented in panels A and B. Results are meansF
Myocytes were unstimulated (Control) or exposed to ET-1 (100 nM, 60 min)
oligonucleotide in the absence or presence of the indicated fold excess of unla
independent preparations of myocytes.first identified as a substrate for PKA, it may also be
phosphorylated by a number of other protein kinases in-
cluding MSK1, a kinase which is downstream of the p38-
MAPK and ERK cascades [6,7]. A range of different stimuli
may therefore be expected to increase phosphorylation of
CREB(Ser-133) to promote CRE-dependent gene expres-
sion. As expected, a cell-permeable analogue of cAMP
(CPT-cAMP, 100 AM) potently (f 7-fold) and rapidly
(3–5 min) stimulated the phosphorylation of CREB(Ser-
133) in neonatal cardiac myocytes (Fig. 1A). ET-1 (100
nM), which does not induce an increase in cAMP in cardiac
myocytes [16], stimulated CREB(Ser-133) phosphorylation
to a similar degree as CPT-cAMP, though the response
appeared more prolonged (Fig. 1B). PE (100 AM) had a
lesser effect (f 5-fold stimulation) and the time course was
delayed (maximal phosphorylation at 10–20 min) (Fig. 1C).
Hyperosmotic shock (0.5 M sorbitol), a severe cellular
stress, also promoted phosphorylation of CREB(Ser-133)
(f 5-fold) but over a longer time course (maximal phos-
phorylation at f 30 min) (Fig. 1D). Total levels of CREB
showed no significant change in any of these experiments.
CREB is therefore phosphorylated and activated in cardiac
myocytes in response to a range of stimuli. Phosphorylation
of CREB in response to cAMP (via PKA) is well-estab-
lished [10]. Since, ET-1 decreases cAMP in cardiac myo-
cytes [16], kinases other than PKA must promoteponse to ET-1 stimulation. A and B, Rat embryonic fibroblasts (A) or rat
for the times indicated. Nuclear extracts were analyzed by EMSA using a
e seen at the bottom of the autoradiograph in panel A. (C) Densitometric
S.E. for three independent preparations of fibroblasts or myocytes. (D)
. Nuclear extracts were analyzed by EMSA using a radiolabeled cCRE
beled cCRE or HSE oligonucleotides. Results are representative of three
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tently promotes the activation of the ERK cascade in cardiac
myocytes [17] and also stimulates p38-MAPKs [18]. Phos-
phorylation of CREB(Ser-133) induced by ET-1 was com-
pletely suppressed by inhibition of the ERK cascade
(U0126, 10 AM) (Fig. 2), strongly implicating the ERK
cascade in the response. However, an inhibitor of p38-
MAPKa/h (SB203580, 10 AM) also partially suppressed
the response (43.1F 8.3% inhibition, n = 3), suggesting that
there may be some contribution from this pathway.
3.2. Phosphorylation of CREB has no effect on DNA
binding activity
A number of studies suggest that phosphorylation of
CREB(Ser-133) increases DNA binding, although other
studies indicate that this is not the case [6]. To determine
whether, in cardiac myocytes, phosphorylation of
CREB(Ser-133) in response to ET-1 had any effect on
DNA binding activity, EMSAs were performed using an
oligonucleotide containing a consensus cCRE sequence to
which CREB should bind or, for comparison, a cAP-1
sequence to which Fos/Jun dimers should bind. Nuclear
extracts were prepared from rat embryonic fibroblasts or ratFig. 4. Transcription factor binding to a cAP-1 sequence increases in response to
ventricular myocytes (B) were unstimulated or exposed to 100 nM ET-1 for the tim
oligonucleotide containing a cAP-1 sequence. The free probe can be seen at th
autoradiographs represented in panels A and B. Results are meansF S.E. for thre
unstimulated (Control) or exposed to ET-1 (100 nM, 60 min). Nuclear extracts w
absence or presence of the indicated fold-excess of unlabeled cCRE or HSE oligo
myocytes.neonatal cardiac myocytes exposed to ET-1 to determine
whether any effects were cell-type-specific. Using the cCRE
sequence, we detected two distinct bands with nuclear
extracts from either embryonic fibroblasts (Fig. 3A) or
neonatal cardiac myocytes (Fig. 3B), but there was no
increase in either of these bands in response to ET-1
stimulation (Fig. 3A–C). Competition assays were per-
formed to confirm that both bands represented specific
binding of transcription factor complexes. As expected,
unlabeled cCRE competed efficiently for transcription factor
binding (both bands) to the labeled oligonucleotide, whereas
an unrelated sequence based on a HSE showed no compe-
tition (Fig. 3D). In contrast to EMSAs with the cCRE
oligonucleotide, a single band was detected with the cAP-
1 oligonucleotide and transcription factor binding was
increased from f 15 min in nuclear extracts from embry-
onic fibroblasts and f 45 min in nuclear extracts from
neonatal cardiac myocytes (Fig. 4A–C), confirming that
ET-1 promoted an increase in the AP-1 complex in fibro-
blasts and cardiac myocytes. As expected, unlabeled cAP-1
competed for transcription factor binding to the labeled
oligonucleotide, whereas the HSE sequence showed no
competition (Fig. 4D). Preincubation of myocyte nuclear
extracts with antibodies to CREB completely abolished theET-1 stimulation. A and B, Rat embryonic fibroblasts (A) or rat neonatal
es indicated. Nuclear extracts were analyzed by EMSA using a radiolabeled
e bottom of the autoradiograph in panel A. (C) Densitometric analysis of
e independent preparations of fibroblasts or myocytes. (D) Myocytes were
ere analyzed by EMSA using a radiolabeled cCRE oligonucleotide in the
nucleotides. Results are representative of three independent preparations of
Fig. 6. Transcription factor binding to the jun1 sequence does not change in res
consensus cCRE and cAP-1 sequences. B and C, Rat embryonic fibroblasts (B) or
nM ET-1 for the times indicated. Nuclear extracts were analyzed by EMSA using
can be seen at the bottom of the autoradiograph in panel B. (D) Densitometric
meansF S.E. for three independent preparations of fibroblasts or myocytes. (E) M
Nuclear extracts were analyzed by EMSA using a radiolabeled jun1 oligonucleotid
HSE oligonucleotides. Results are representative of three independent preparation
Fig. 5. Cardiac myocyte transcription factor complexes containing either
CREB or c-Jun interact a cCRE sequence. Myocytes were unstimulated or
exposed to ET-1 (100 nM, 60 min). Nuclear extracts were analyzed by
EMSA using a radiolabeled cCRE oligonucleotide in the absence or
presence of specific antibodies (ab, 1 Ag). (A) Antibodies to CREB
interacted with the complex which formed the lower band (arrow)
producing a supershift band (*). (B) Antibodies to c-Jun interacted with
the complex which formed the upper band (arrow) producing a supershift
band (*). Results are representative of three independent preparations of
myocytes.
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in the appearance of a more slowly migrating complex (Fig.
5A, bands marked with an arrow and asterisk, respectively).
The upper band which was detected on EMSAs with the
cCRE contained c-Jun since preincubation with c-Jun anti-
bodies resulted in a supershift of this band (Fig. 5B). It is
therefore clear that, although ET-1 promotes phosphoryla-
tion of CREB(Ser-133) (Fig. 1B) and CREB (as expected)
binds to a cCRE sequence (Fig. 5A), this does not affect the
binding activity of CREB to the cCRE (Fig. 3) even though
transcription factor binding to the cAP-1 oligonucleotide is
increased (Fig. 4).
3.3. The proximal CRE-/AP-1-like element in the c-jun
promoter resembles a cCRE sequence
The c-jun promoter contains a number of transcription
factor binding sites, but two CRE-/AP-1-like sites have been
particularly implicated in its regulation [19–21]. It has
further been proposed that heterodimers of c-Jun andponse to ET-1 stimulation. (A) Comparison of the rat jun1 sequence with
rat neonatal ventricular myocytes (C) were unstimulated or exposed to 100
a radiolabeled oligonucleotide containing the jun1 sequence. The free probe
analysis of autoradiographs represented in panels B and C. Results are
yocytes were unstimulated (Control) or exposed to ET-1 (100 nM, 60 min).
e in the absence or presence of the indicated fold-excess of unlabeled jun1 or
s of myocytes.
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positive feedback system exists in which c-Jun is upregu-
lated in response to stimuli and acts at the CRE-/AP-1-like
sites to promote further upregulation of c-jun mRNA. Other
studies have placed CREB, rather than c-Jun/ATF-2 at both
the proximal [24] and distal [25] CRE-/AP-1-like sites. The
sequence of the most proximal of these sites (jun1) is similar
to both cCRE and cAP-1 (Fig. 6A). To determine whether
jun1 resembles a cCRE or cAP-1, EMSAs were performed
using oligonucleotides which contained the jun1 sequence.
With this sequence, as with the cCRE oligonucleotide (Fig.
3A,B), two bands were detected using nuclear extracts from
either embryonic fibroblasts (Fig. 6B,D) or neonatal cardiac
myocytes (Fig. 6C,D), and there was no significant change
in intensity of either of these bands in response to ET-1
stimulation. As expected, unlabeled jun1 competed effi-
ciently for transcription factor binding to the labeled oligo-
nucleotide, whereas the HSE sequence showed no
competition (Fig. 6E). Preincubation of myocyte nuclear
extracts with antibodies to CREB reduced the intensity of
the lower band, but did not completely abolish it even when
the antibody concentration was increased (Fig. 7A). Thus,
although complexes containing CREB are a component of
this band, other transcription factors are also present. As
with the cCRE, the upper band contained c-Jun since
preincubation with c-Jun antibodies decreased the intensity
of this band and resulted in the appearance of a complex of
greater relative molecular mass (Fig. 7B). Increasing the
antibody concentration had no additional effect (results not
shown) indicating that complexes containing other tran-
scription factors are also present. c-Jun may therefore act
at the jun1 element to promote expression of c-jun, but there
is no evidence that the increase in c-Jun protein which
occurs in myocytes in response to ET-1 [26] and whichFig. 7. Cardiac myocyte transcription factor complexes containing either
CREB or c-Jun interact the jun1 sequence. Myocytes were unstimulated or
exposed to ET-1 (100 nM, 60 min). Nuclear extracts were analyzed by
EMSA using a radiolabeled jun1 oligonucleotide in the absence or presence
of the indicated amount of specific antibodies (ab). (A) Antibodies to
CREB partially interacted with the complex which formed the lower band
(arrow) producing a supershift band (*). (B) Antibodies to c-Jun partially
interacted with the complex which formed the upper band (arrow)
producing a supershift band (*). Results are representative of three
independent preparations of myocytes.presumably contributes to the increase in cAP-1 binding
(Fig. 4) constitutes a positive feedback system.4. Discussion
The significance of CREB(Ser-133) phosphorylation in
the heart is highlighted by the dilated cardiomyopathy
resulting from cardiac-specific overexpression of a mutant
form of CREB which cannot be phosphorylated and thus
inhibits CREB-dependent gene expression [9]. Although
CREB has been recognized as a substrate for PKA for some
time, and isoproterenol signaling through cAMP! PKA
increases CREB(Ser-133) phosphorylation in cardiac myo-
cytes [10], a number of other signaling pathways can also
induce CREB(Ser-133) phosphorylation to promote gene
expression [6]. In this study, we have shown that, in addition
to cAMP/PKA, hypertrophic agonists and hyperosmotic
shock (as an example of cell stress) also promote phosphor-
ylation of CREB(Ser-133) in cardiac myocytes (Fig. 1). The
initial response to ET-1 was similar to that induced by CPT-
cAMP. However, the increase in CREB(Ser-133) phosphor-
ylation induced by ET-1 was mediated largely through the
ERK cascade with possibly some input from p38-MAPKa/
h (Fig. 2). In this context, the CREB kinases are presumably
either RSKs (which are activated by ERKs) or MSK1
(which can be activated by either ERKs or p38-MAPKs)
[6]. Although the principal effect of CREB(Ser-133) phos-
phorylation is to increase its trans-activating activity, some
studies have suggested that it may also increase its affinity
for DNA and thus the DNA-binding activity [6]. However,
CREB-binding to either the cCRE or jun1 sequences did not
change in nuclear extracts from cardiac myocytes or fibro-
blasts exposed to ET-1 (Figs. 3 and 6) despite the increase in
CREB(Ser-133) phosphorylation (Fig. 1B). Thus, the prin-
cipal effect of CREB phosphorylation on gene expression is
probably through an increase in trans-activating activity.
Immediate early genes such as c-jun rely on the presence
of pre-existing transcription factors which are probably pre-
bound to specific regulatory elements in the promoter and
which are regulated by phosphorylation. The rat c-jun
promoter region contains several such elements including
two AP-1/CRE-like sites [19]. which are the dominant
elements in the upregulation of c-jun expression under some
circumstances [20,21]. These sites bind heterodimers of c-
Jun and ATF2 in some cells [22,23], the trans-activating
activities of which are increased by phosphorylation by
JNKs and p38-MAPKs (potentially) [27–31]. Through this
mechanism, it has been proposed that c-Jun can upregulate
its own expression. However, our previous work demon-
strated that, in cardiac myocytes, the ERK cascade is
required for upregulation of c-jun mRNA, although phos-
phorylation of c-Jun by JNKs is necessary to increase
protein stability for efficient upregulation of c-Jun protein
[26]. These previous studies suggested that c-Jun does not
operate in a positive feedback loop to upregulate its own
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study. Thus, the increase in c-Jun protein induced by ET-1
[26] correlates with an increase in cAP-1-binding activity
(Fig. 4), which contains Jun family proteins (c-Jun, JunB;
results not shown). However, there is no increase in tran-
scription factor binding to jun1 (Fig. 6) even though c-Jun is
present in one of the complexes (Fig. 7). Presumably, this
reflects the presence of a different transcription factor in the
c-Jun heterodimer which binds to the jun1 element and
which is presumably not upregulated, compared with the
dimers which bind to the cAP-1 sequence.
Although c-Jun/ATF2 dimers were first implicated in
regulating c-jun expression via the two CRE-/AP-1-like
sites [22,23], subsequent studies indicated that CREB and
ATF1 interact with the jun1 element and this, together with
a more proximal binding site for MEF2, is required for
upregulation of c-jun mRNA in response to epidermal
growth factor [24]. It is therefore possible that different
transcription factor dimers may act at the jun1 element in
specific cell types and/or under different conditions. In rat
cardiac myocytes and embryonic fibroblasts, we determined
that the jun1 sequence more closely resembled a cCRE
sequence than a cAP-1 sequence with respect to transcrip-
tion factor binding (Figs. 3, 4 and 6). Like the cCRE, two
dominant bands were seen using EMSAs, with CREB
present in the lower band and c-Jun present in the upper
band (Fig. 7). However, with jun1, complexes were present
in both bands which did not contain either CREB or c-Jun,
suggesting that the regulation of this element may be
mediated through additional transcription factors. Although
EMSAs can provide an indication of which transcription
factors can operate at a particular element in the promoter of
a specific gene, in the context of a whole cell, certain
transcription factor complexes may bind preferentially to
specific elements in the promoters of other genes and thus
be unavailable for binding to the promoter of interest.
Clearly, further studies are required to identify the transcrip-
tion factors which operate within the c-jun promoter in
cardiac myocytes in vivo.Acknowledgements
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